Pancreas Ultrasound Imaging in type1 Diabetes (NCT05482321)
Contrast Enhanced Ultrasound Imaging of Pancreas Blood Flow in type1 Diabetes
๐ฉบ Plain-English Summary (8th-Grade Level)
The overall goal of this study is to develop and test a novel method involving ultrasound imaging, in order to detect the development of type 1 diabetes. In this study the investigators will first establish a standard operating procedure for measuring pancreas blood flow speed and volume in the pancreas of human subjects. The investigators will then determine 1) whether these pancreas blood flow factors differ between healthy subjects and those who have recently developed type1 diabetes; and 2) how variable measurements are in healthy subjects and subjects that recently developed type1 diabetes, both between subjects and over time. To address these aims the investigators will perform pancreas ultrasound measurements in each subject using an approved injectable 'bubble' contrast agent that allows measurement of pancreas blood flow. The investigators will compare ultrasound measurement with characteristics of the subject's type 1 diabetes, including genetic factors, glucose levels and other circulating factors, as well as other factors that may influence blood flow in the pancreas independent of type1 diabetes. The successful conclusion of this study will indicate whether measuring pancreas blood flow speed/volume will be helpful in monitoring whether type1 diabetes will emerge and thus will allow a large scale study to answer this question.
Who can join: Review the eligibility criteria below.
Location: University of Colorado Anschutz, Barbara Davis Center โ Aurora, Colorado
Age range: 18 Years to 65 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of Colorado Anschutz, Barbara Davis Center โ Aurora, Colorado
๐ Contact the Study Coordinator
Phone: (303) 724-7526
Email: morgan.sooy@cuanschutz.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type1diabetes
- Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes โ New Haven, Connecticut
- REACHOUT Mental Health Support Mobile App โ Vancouver, British Columbia
- Effects of Ketosis on Brain Function in Patients With T1DM โ Boston, Massachusetts
- Genetics Of Autoimmunity In Type I Diabetes โ Milwaukee, Wisconsin
- Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes โ Montreal, Quebec
Explore by condition: All Type1diabetes clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.